Stocks With Mixed Gains: Radiant Logistics Inc (RLGT), Actinium Pharmaceuticals Inc (ATNM) and DARA Biosciences Inc (DARA)
New York, NY – GDP INSIDER – 04/27/2014.
This article discusses three companies: Radiant Logistics Inc (NYSEMKT:RLGT), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) and DARA Biosciences Inc (NASDAQ:DARA)
Radiant Logistics Inc (NYSEMKT:RLGT) continued to climb on Friday with the stock gaining 2.19% or $0.12 to close the day at a closing price of $5.60 with 0.101 million shares changing hands, compared to its three month average trading volume of 0.126 million. The stock, which traded within a range of $5.44 to $5.60 during the day, is currently trading 9.18% above its 50 day moving average of $5.15 and 36.91% above its 200 day moving average of $4.10. With quarterly revenue growth (yoy) of 25.90% and one year target price of $6.33, the stock could indicate gains in the near term, but is a hold for now.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) saw a decrease of 2.64% or $0.08 to finish the day at a closing price of $2.95 on lower than average trading volume of 0.234 million shares, compared to its three month average trading volume of 0.387 million. The US-based biopharmaceutical company developing cancer drugs is currently situated 78.47% below its 52 week high of $16. Over the past one week and over the past one quarter, the shares of Actinium Pharmaceuticals Inc have lost 12.72% and 42.83%, respectively. However, with RSI of 47.72 and one year target price estimate of $16, the stock has plenty of upside potential, hold.
DARA Biosciences Inc (NASDAQ:DARA) continued to climb on Friday s the stock gained four cents to finish the day at a closing price of $0.81,an 5.91% increase in value from its previous closing price, on much higher than average trading volume of 0.928 million, compared to its three month average trading volume of 0.248 million. The US-based company, which focuses on the commercialization of oncology treatment and oncology supportive care products, is trading below its 50 day moving average of $0.813 and 200 day moving average of $0.950. However, with positive quarterly revenue growth (yoy) of 250% and one year price target estimate of $2, DARA Biosciences Inc has still plenty of upside making it a hold.
About Ultimate Stock Alerts
UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com
Disclosure: UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.